Live · Open opportunity
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
- Issuer
- National Institutes of Health
- Type
- Federal funding opportunity
- Jurisdiction
- federal
- Posted
- June 8, 2026
- Closes
- October 9, 2026
Detail
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal…
View the full solicitation and how to apply ↗
Free account
Create a free account
Track New York opportunities and save searches across the Market. Free. No card required.
Want a strategy to win work like this? Build your Market Network Strategic Plan →
